USPTO serial 87945001
Serial No. 87945001
Reviewed by CopyMark Law Group
Reg. 5660453Status 710
- Filing date
- Status date
- Registration date
- Jan 22, 2019
- Examiner
- STOIDES, KATHERINE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with Serial No. 87945001?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Edward T. White
Edward T. White Williams Mullen200 South 10th Street, Suite 1600Williams Mullen CenterRichmond, VA 23219Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | chemical compounds for use in bio-pharmaceutical research | SECTION 8 - CANCELLED | Dec 1, 2008 |
| 005 | Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of inflammation; pharmaceutical preparations for the treatment of immune-mediated conditions; pharmaceutical preparations for the treatment of neuro-degenerative diseases | SECTION 8 - CANCELLED | Feb 28, 2018 |
| 042 | research and development of pharmaceuticals for others; research and development of pharmaceuticals for the treatment of cancer; research and development of pharmaceuticals for the treatment of inflammations; research and development of pharmaceuticals for the treatment of immune-mediated conditions; research and development of pharmaceuticals for the treatment of neuro-degenerative diseases; scientific and medical research in the fields of oncology, immunology and immune-oncology, inflammation, immune-mediated diseases, protein homeostasis, epigenetics and protein metabolism | SECTION 8 - CANCELLED | Jun 14, 2017 |
| 044 | Providing a web site featuring information relating to the biology of potential medical treatment such as protein homeostasis, epigenetics, protein metabolism and/or immunology | SECTION 8 - CANCELLED | Jun 14, 2017 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Forma Therapeutics, Inc.
- Other trademarks owned by Forma Therapeutics, Inc.
- Other trademarks owned by Forma Therapeutics, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 1, 2025 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jan 22, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Sep 10, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 10, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 10, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 10, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 10, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Apr 14, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 14, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 14, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 14, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 14, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jan 22, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 6, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 6, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 17, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 27, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 21, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 21, 2018 | ALIE | ASSIGNED TO LIE | — |
| Sep 21, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 21, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 21, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 20, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 9, 2018 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jun 8, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 5, 2018 | NWAP | NEW APPLICATION ENTERED | — |